Amneal
AMRX
Amneal (AMRX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $22.00 | Aug 26, 2026 |
| UBS | Maintained | Buy | $25.00 from $23.00 | Aug 3, 2026 |
| UBS | Maintained | Buy | $23.00 from $19.00 | Jul 15, 2026 |
| Barclays | Maintained | Overweight | $16.00 from $15.00 | May 20, 2026 |
| UBS | Initiated Coverage | Buy | $19.00 | Apr 17, 2026 |
| Truist Securities | Maintained | Buy | $17.00 from $15.00 | Mar 2, 2026 |
| Barclays | Initiated Coverage | Overweight | $15.00 | Dec 9, 2025 |
| Piper Sandler | Maintained | Overweight | $13.00 from $11.00 | Oct 31, 2025 |
| JP Morgan | Maintained | Overweight | $14.00 from $12.00 | Sep 16, 2025 |
| Barclays | Maintained | Overweight | $11.00 from $10.00 | Mar 3, 2025 |
| JP Morgan | Upgraded | Neutral → Overweight | $12.00 from $9.00 | Feb 24, 2025 |
| Piper Sandler | Maintained | Overweight | $11.00 from $9.00 | Nov 11, 2024 |
| Truist Securities | Maintained | Buy | $12.00 from $10.00 | Oct 2, 2024 |
| JP Morgan | Upgraded | Underweight → Neutral | $9.00 | Sep 6, 2024 |
| Barclays | Maintained | Overweight | $10.00 from $8.00 | Aug 13, 2024 |
| Truist Securities | Maintained | Buy | $10.00 from $9.00 | Aug 12, 2024 |
| Truist Securities | Maintained | Buy | $9.00 from $7.00 | May 6, 2024 |
| Goldman Sachs | Maintained | Buy | $8.00 from $6.25 | May 6, 2024 |
| Piper Sandler | Maintained | Overweight | $8.00 from $6.00 | Mar 21, 2024 |
| Goldman Sachs | Maintained | Buy | $6.25 from $5.50 | Mar 4, 2024 |
Frequently asked questions
What is the latest analyst rating on AMRX?
On Aug 26, 2026, JP Morgan maintained Amneal at Overweight with a price target of $22.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.